R&D | May 28, 2026
Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
Highlighting KEYTRUDA & expanding cancer pipeline
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona
SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
Subscribe To Our Newsletter & Stay Updated
